SCHEMBL7338773

SCHEMBL7338773

CC(C(N)=O)N(C(=O)C(Cc1ccccc1)CS(=O)(=O)N1CCOCC1)n1cccn1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.38
REN P00797 1/20 0.37
ALDH1A1 P00352 5/20 0.36
HTT P42858 1/20 0.36
CYP2C19 P33261 2/20 0.36
CYP2C9 P11712 1/20 0.36
CTSS P25774 1/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
GAA P10253 2/20 0.35
MAPT P10636 1/20 0.34
POLB P06746 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
NAPEPLD Q6IQ20 1/20 0.33
USP2 O75604 1/20 0.33
TSHR P16473 1/20 0.32
MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7337567 0.90 REN (0.38) RENALDH1A1CYP2C19CTSSGAA
SCHEMBL7337794 0.90 KMT2A (0.43) RENALDH1A1CTSSKMT2ATSHR
SCHEMBL7330525 0.87 REN (0.38) RENCTSSTSHR
SCHEMBL7338677 0.87 CTSS (0.34) RENCTSS
SCHEMBL7332722 0.86 LMNA (0.38) LMNARENALDH1A1HTTCYP2C19
SCHEMBL7331654 0.85 RORC (0.34) CTSSKMT2A
SCHEMBL7332734 0.84 REN (0.42) RENALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL7337422 0.79 REN (0.40) LMNARENALDH1A1HTTCYP2C19
SCHEMBL7339877 0.78 LMNA (0.38) LMNARENALDH1A1HTTCYP2C19
SCHEMBL7330457 0.77 REN (0.39) LMNARENALDH1A1HTTCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5332742-A Ocular hypotensive ABBOTT LABORATORIES (US) 1994-07-26 US disclosed
US-5310740-A Congestive heart failure, hypotensive agents, antiglaucoma agents; side effect reduction ABBOTT LABORATORIES (US) 1994-05-10 US disclosed
US-5284849-A Treating hypertension and congestive heart failure ABBOTT LABORATORIES (US) 1994-02-08 US disclosed
EP-0456185-A2 Renin inhibitors ABBOTT LABORATORIES (US) 1991-11-13 EP disclosed